Shanghai Pharmaceuticals Holding (HKG:2607, SHA:601607) reported a net profit attributable to shareholders of 1.11 billion yuan for the quarter ended Sept. 30, a decrease of 6.29% compared with the prior-year period, according to a quarterly report filed on Tuesday with the Hong Kong Stock Exchange.
Earnings per share for the company were 0.30 yuan, down 0.06% year on year.
The company's operating revenue grew 8.16% on-year to 70.22 billion yuan.
The pharma company's shares were down over 3% in the recent trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments